Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
August 30, 2025
Not intended for U.S. and UK Media
Data from Phase III VICTOR clinical trial of vericiguat presented at ESC Congress 2025
August 18, 2025
Monsanto reaches agreements in principle to resolve additional PCB cases at the Sky Valley Education Center
Discover More
